OBJECTIVE: To evaluate the in¯uence of family history of hypertension on insulin sensitivity in obese normotensive adults, comparing them with lean subjects. SUBJECTS: 136 normotensives (N)(mean 24 h blood pressure`130a80 mmHg; age range 35 ± 45 y): 32 lean (body mass index, BMI 25 kgam 2 ) N with normotensive parents (F7), 37 lean N with one or two parents hypertensive (F), 32 obese (BMI ! 30 kgam 2 ) NF7 and, 35 obese NF. METHODS: 24 h ambulatory blood pressure monitoring; glucose, insulin and C-peptide before and 30, 60, 90 and 120 min after an oral glucose load; index of insulin peripheral activity (Ia: 10 4 ainsulin Â glucose values at glucose peak); fasting insulinaC-peptide ratio (IaCp). RESULTS: The four groups were comparable for age, gender and blood pressure values throughout the 24 h. Glucose, fasting and during test, and IaCp were similar among the four groups; insulin and C-peptide, fasting and stimulated, were signi®cantly higher and Ia lower in obese N than in lean N; at similar BMI, insulin and C-peptide were signi®cantly higher and Ia lower, in F than in F7. The correlation between insulin and BMI was signi®cantly closer in F7 than in F. CONCLUSIONS: Family history of hypertension appears to be signi®cantly associated with insulin sensitivity in both lean and obese normotensive adults; moreover, overweight and a genetic predisposition to hypertension may have additive adverse effects on insulin sensitivity in normotensive adult subjects.
Introduction
In recent years, growing attention has been paid to the role of genetic factors in linking insulin resistance and essential hypertension. 1, 2 These two conditions are often associated, but the pathophysiological meaning of this connection is still under evaluation. 3 ± 5 The relevance of genetic predisposition has been investigated both in experimental and clinical studies. Reed et al 6 demonstrated that insulin resistance, induced by a fructose enriched diet, was accompanied by an increase in blood pressure in only one of the three strains of rats examined. 6 In humans, many studies have found a reduced insulin sensitivity in lean young normotensives with hypertensive parents, compared to offspring of normotensives 7 ± 12 and similar ®ndings have been obtained in lean adult hypertensives. 13, 14 Offspring of hypertensives are also particularly prone to gaining weight 15, 16 and it is known that excess body weight, and central obesity in particular, resulting from intrinsic disturbances andaor excess energy intake, are per se associated with insulin resistance. 17, 18 We have recently found that in middle-aged obese hypertensives, insulin sensitivity is lower in offspring of hypertensives than in subjects with normotensive parents. 19 Therefore we considered it of interest to evaluate whether a genetic background of hypertension can also in¯uence insulin sensitivity in obese normotensive adults, comparing them with lean normotensive subjects matched for age and gender.
Methods

Patients
We selected normotensive (N) subjects aged between 35 and 45 y, lean (body mass index, BMI 25 kgam 2 ) or obese with upper body obesity (BMI ! 30 kgam 2 ; waistahip ratio (WHR): men b 0.92, women b 0.82), with fasting plasma glucose`5.6 mmolal, plasma cholesterol`5.2 mmolal and HDL-cholesterol b 1.04 mmolal, plasma triglycerides`1.8 mmolal and without a family history of diabetes mellitus.
The subjects were recruited partly from an epidemiological survey of the employees of the Postal and Telegraph services, and partly from obese subjects followed at the out-patients' department of endocrinology, and offspring of hypertensives followed at the out-patients' department of hypertension.
Arterial blood pressure (BP) was evaluated on the basis of at least three measurements by sphygmomanometer, taken on different days. Subjects were de®ned as normotensive when BP was`135a85 mmHg. Subsequently each subject underwent 24 h noninvasive ambulatory BP monitoring, that con®rmed normal BP (mean 24 h BP`130a80 mmHg) in all the subjects selected.
Family history of hypertension was assessed on the basis of parents' history and BP. Negative family history (F7) was established when both parents were living and had BP`140a90 mmHg; positive family history (F) was established when at least one parent was living and had BP b 160a95 mmHg or one or both parents had a history of chronic antihypertensive treatment. Parental BP was measured by sphygmomanometer three times on different days, by one of the investigators.
Following these criteria, we selected 136 normotensive subjects: NF7: 32 lean normotensives (20 men) with both parents normotensive. NF: 37 lean normotensives (23 men) with one (24 subjects) or both parents hypertensive. ONF7: 32 obese normotensives (20 men) with both parents normotensive. ONF: 35 obese normotensives (22 men) with one (22 subjects) or both parents hypertensive.
All the subjects were judged healthy on the basis of history, clinical examination and routine blood tests.
No subject was taking any drug or was involved in sustained physical activity, and no subject had changed body weight or dietary habits for at least six months before the study. The study was approved by the Ethical Committee of the Department of Clinical and Biological Sciences and all the subjects gave their informed consent.
Protocol
Two or three days after the 24 h ambulatory BP monitoring, each subject underwent, at 08.00 h, after an overnight fast, a 75 g oral glucose tolerance test (OGTT). Plasma glucose (G), serum insulin (I) and Cpeptide (Cp) were determined before and 30, 60, 90 and 120 min after the glucose load. The values obtained during OGTT have been expressed as area under the curve (AUC), measured with the trapezoidal rule. Using insulin (Ip) and glucose (Gp) values at the glucose peak, we calculated an index of peripheral insulin activity (Ia): Ia 10 4 aIpGp. 20 We also evaluated fasting insulinaC-peptide ratio (IaCp), as index of hepatic I clearance.
Serum insulin was measured by an antibody method with a solid-phase 125 I radioimmunoassay (RIA) (Coat-A-Count Insulin, DPC) as was the C-peptide (C-peptide, Biodata, Rome, Italy). The method for insulin measurement has a sensitivity of 1.1 mUal and a coef®cient of variation of 7.1% at I values of 1± 40 mUaI. For Cp determination, the method has a sensitivity of 0.1 mgal and a coef®cient of variation of 3.5% at Cp values of 0.5±6.5 mgal.
h ambulatory BP monitoring
Noninvasive ambulatory BP monitoring was performed with a portable automated Takeda TM 2420 and simultaneous 24 h heart rate monitoring was obtained. The unit was set to take readings every 15 min throughout the 24 h. The following parameters were evaluated: mean 24 h, day-time (from 07.00 to 22.00 h) and night-time (from 22.00±07.00 h) systolic and diastolic BP and heart rate, % nocturnal fall of systolic and diastolic BP (day BP7night BPaday BP Â 100).
Statistical analysis
The statistical evaluation of the results was carried out by means of one-way analysis of variance (ANOVA) on the four groups, unpaired t-test for comparison between NF7 and NF, and between ONF7 and ONF, and Pearson's linear correlation coef®cients. All the variables were normally distributed and the variances were homogeneous across the groups; a P value`0.05 was considered statistically signi®cant.
Results
The four groups were comparable (ANOVA not statistically signi®cant, NS) as regards age, gender, heart rate and BP values throughout the 24 h; BMI was similar between NF7 and NF, and between ONF7 and ONF ( Table 1) . The WHR was comparable between ONF7 (0.97 AE 0.08) and ONF (0.95 AE 0.09). 
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Fasting G and IaCp ratio were similar in the four groups. Fasting I and Cp were signi®cantly different among groups, being higher in the obese groups compared to the lean groups; at similar BMI, I and Cp were signi®cantly higher in F than in F7 (Table  2) . During OGTT, G values were within the normal limits in all subjects and similar among the four groups at each point of the curve; I and Cp were signi®cantly higher at each point of the curve in obese N compared to lean N and, at similar BMI, in F than in F7 (Figure 1) . Therefore, I-AUC and Cp-AUC were higher and Ia lower in obese N than in lean N and, at similar BMI, in F than in F7 (Table 2) .
BMI was directly correlated with fasting I and I-AUC in all the four groups, but the correlation was signi®cantly weaker (P`0.01) in the two groups with positive family history of hypertension (Table 3) .
In NF7 and ONF7, metabolic parameters did not correlate with ambulatory BP values; in NF and ONF fasting I and I-AUC were directly correlated with the extent of nocturnal systolic BP fall (fasting I: NF, r 0.43, P`0.01; ONF, r 0.45, P`0.01. I-AUC: NF, r 0.45, P`0.01; ONF, r 0.46, P`0.01).
Discussion
Designing this study we paid attention to select true normotensive subjects, evaluating BP not only by means of repeated casual measurements, but also by using 24 h ambulatory monitoring; parents' BP was directly and repeatedly assessed, in order to avoid the recruitment of subjects with incorrectly de®ned family history of hypertension. We also excluded from the study subjects with family history of diabetes, a factor known to in¯uence insulin sensitivity.
21 Figure 1 Mean values of plasma glucose, serum insulin and C-peptide at each point of the OGTT curve in lean normotensives (N) and obese normotensives (ON) with (F) and without (F7) family history of hypertension. From unpaired t-test: ONF vs ONF7 P`0.005, P`0.001; NFvs NF7* P`0.005, ** P`0.001. NS not statistically signi®cant. 
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Despite normal and similar values of fasting and stimulated plasma glucose, the four groups of subjects showed signi®cant differences as regards insulin and C-peptide: both fasting and during OGTT, insulin and C-peptide were higher in obese than in lean subjects. This result, in keeping with the data from literature, 17, 22, 23 con®rms a reduced insulin sensitivity in obese people. However, at a similar BMI, we found that fasting and stimulated insulin and C-peptide were higher in subjects with positive family history of hypertension than in subjects with normotensive parents. From insulin and glucose values at the glucose peak we derived an index that has been demonstrated to fairly approximate peripheral insulin activity. 20 It was lower in obese than in lean subjects and, at similar BMI, in offspring of hypertensives than in offspring of normotensives. The differences among the groups were not due to a different hepatic clearance of insulin, as the insulinaC-peptide ratio was similar in the four groups.
Insulinaemia is not a direct measurement of insulin sensitivity, however fasting insulin levels and insulin during OGTT correlate well with standard measurements of insulin sensitivity, obtained by means of a euglycemic clamp. 24, 25 Therefore, fasting and postload hyper-insulinaemia, associated with normal and similar values of plasma glucose, can be considered a reliable index of insulin resistance. 25 ± 27 From our results, also taking into account the index of peripheral insulin activity, insulin sensitivity is reduced in both lean and obese normotensive adults with hypertensive parents compared with offspring of normotensives. We have to underline that the four groups of subjects were similar as regards age and gender distribution, as well as BP values throughout the 24 h. Moreover, as the pattern of fat distribution in¯uences insulin sensitivity, 28, 29 we selected subjects with upper body obesity and the WHR was similar between the two obese groups. Therefore, the difference in insulin levels among the four groups cannot be explained by differences in age, gender, BP or body fat distribution. The reduced insulin sensitivity appears to be mainly related to a genetic predisposition, whose relevance is also indirectly indicated by the correlation between BMI and insulinaemia. In fact, as previously found, 12,30 ± 32 fasting and stimulated insulinaemia were directly correlated with BMI in all the four groups, but the correlations were signi®cantly closer in the two groups with normotensive parents. The weaker correlations between insulinaemia and BMI in subjects with a positive family history of hypertension suggest that genetic predisposition to hypertension in¯uences insulin sensitivity, partly separating it from the body weight.
Metabolic parameters did not correlate with BP in the two groups with normotensive parents, whereas in offspring of hypertensives, fasting and stimulated insulinaemia directly correlated with the extent of nocturnal BP decrease.
Our study on normotensive subjects was not aimed to evaluate the hypothesis of a causal relationship between hyperinsulinaemia and hypertension, however we have to notice that this pattern of correlation (the higher the insulinaemia, the lower the night-time BP) does not support the hypothesis that hyperinsulinaemia plays a causal role in the development of hypertension.
Conclusion
Family history of hypertension appears to signi®cantly in¯uence insulin sensitivity, not only in lean, but also in obese normotensive adults, in keeping with the hypothesis that a genetic background of hypertension carries a predisposition to insulin resistance. Moreover our study demonstrates that fat accumulation and genetic predisposition to hypertension appear to have an additive adverse effect on insulin sensitivity in normo-tensive adult subjects.
